MenQuadfi
MenQuadfi is a medicine authorised by Swissmedic under authorisation number 68221. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Vaccines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 05 October 2022 and the authorisation is limited until 04 October 2027. ATC code J07AH08 places the medicine in the group Vaccines.
| Authorisation number | 68221 |
|---|---|
| Name | MenQuadfi |
| Full name | MenQuadfi, solution injectable |
| Authorisation holder | Sanofi-Aventis (Suisse) SA |
| Medicinal product code | Vaccines |
| Dispensing category | B · Prescription only |
| ATC code | J07AH08 |
| First authorisation | 05 October 2022 |
| Authorisation validity | 04 October 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | MenQuadfi, solution injectable | B | 05 October 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | J07AH08 | 08.08. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is MenQuadfi authorised in Switzerland?
Yes. MenQuadfi is authorised by Swissmedic under authorisation number 68221, data as of 01 September 2026. The authorisation is limited until 04 October 2027.
Which dispensing category does MenQuadfi have?
MenQuadfi is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of MenQuadfi?
The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.